Covidien rearranges portfolio with ev3 purchase
This article was originally published in Clinica
Executive Summary
On the same day that it agreed a multi-billion-dollar deal to acquire endovascular treatment specialist ev3, Covidien also sealed a deal to divest its sleep therapy business.